Complete Guide: Mounjaro vs Wegovy Comparison
Understanding The Fundamental Difference Between Mounjaro And Wegovy Mechanisms
The primary difference between Mounjaro and Wegovy lies in how these prescription-only medicines work in your body. Mounjaro contains tirzepatide, which acts as a dual receptor agonist targeting both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. This dual mechanism may provide enhanced appetite suppression and metabolic effects compared to single-receptor approaches. Wegovy contains semaglutide, which specifically targets GLP-1 receptors only, mimicking your body's natural fullness hormone to reduce appetite and promote satiety after smaller meals.
At EverydayMeds, we recognise that having access to every dose of both medications allows patients and prescribers to make informed decisions based on individual response and tolerance. Our comprehensive stock ensures continuity of care regardless of which medication proves most suitable. The dual mechanism of Mounjaro may appeal to patients seeking maximum metabolic support, while Wegovy's established GLP-1 pathway offers proven efficacy with extensive clinical data. Both medications require dose escalation protocols, making our complete dose availability essential for uninterrupted treatment progression.
Wegovy Dosing Schedule And Pricing: Complete Range From £79.99
The difference between Mounjaro and Wegovy extends to their distinct dosing schedules and associated costs. Wegovy follows a mandatory 16-week escalation: 0.25mg (weeks 1-4) at £79.99, 0.5mg (weeks 5-8) at £94.99, 1mg (weeks 9-12) at £99.99, 1.7mg (weeks 13-16) at £139.99, and 2.4mg maintenance (week 17+) at £209.99. Our Getting Started bundles streamline this progression, with the Intro Duo (0.25mg & 0.5mg) priced at £169.99, providing your first two months' supply in one convenient order. New customers apply code FIRST40 at checkout, while returning patients use DOSE25 to access these competitive prices.
Mounjaro follows a different escalation pattern with its own pricing structure, though both medications share the principle of gradual dose increases to optimise tolerance. Our bundle options recognise that some patients benefit from extended periods at lower doses, hence our Take-It-Slow range allowing flexibility in progression speed. The Ultimate Stability Trio provides three months of 2.4mg maintenance Wegovy for £649.99, ensuring long-term supply security. This comprehensive pricing approach eliminates the uncertainty of switching pharmacies mid-treatment due to stock limitations or pricing fluctuations.
Clinical Evidence: What The Difference Between Mounjaro And Wegovy Trials Show
Clinical trials demonstrate distinct efficacy profiles when examining the difference between Mounjaro and Wegovy. Wegovy's STEP trial programme showed patients achieving approximately 15% average weight loss at 68 weeks when combined with reduced-calorie diet and increased physical activity, as reported by Wilding et al., NEJM, 2021. The SELECT cardiovascular outcomes trial further demonstrated a 20% reduction in major cardiovascular events amongst patients taking Wegovy. These results establish Wegovy's comprehensive benefits beyond weight management alone.
Mounjaro's SURMOUNT trials evaluated tirzepatide's dual receptor mechanism, though direct comparison between trial outcomes isn't appropriate due to different study designs, populations, and endpoints. Both medications require clinical assessment to determine suitability, with individual response varying considerably between patients. The key consideration isn't which medication performed better in trials, but rather which mechanism and dosing approach aligns with your specific health profile and treatment goals.
How Wegovy's GLP-1 Mechanism Differs From Mounjaro's Dual Action
Wegovy works by mimicking GLP-1, a natural hormone released by your intestines after eating that signals fullness to your brain. This mechanism reduces appetite by acting on hypothalamic appetite centres, slowing gastric emptying to prolong satiety, and potentially reducing food cravings throughout the day. The once-weekly FlexTouch pen delivers consistent medication levels, maintaining appetite suppression between doses. Unlike medications that simply block absorption or stimulate metabolism, Wegovy works with your body's existing hunger and satiety pathways. This physiological approach may explain why patients often report feeling naturally less interested in food rather than experiencing forced appetite suppression.
Streamlined Ordering Process For Both Wegovy And Mounjaro
EverydayMeds simplifies access to both medications through our comprehensive online service registered with the GPhC (#9012878). The process begins with a 3-minute clinical assessment covering your medical history, current medications, and weight management goals. Our qualified prescribers review your application within 3 working days (or 24 hours with express service), determining suitability for either Wegovy or Mounjaro based on clinical guidelines and your individual circumstances. Once approved, next-day delivery ensures your medication arrives in temperature-controlled packaging maintaining the cold-chain from our pharmacy to your door. This seamless process continues throughout your treatment, with automatic reminders and easy reordering ensuring continuity of care.
Storage And Practical Considerations: Wegovy's Travel Advantage
A practical difference between Mounjaro and Wegovy involves storage requirements and travel convenience. Both medications require refrigeration at 2-8°C before first use, but Wegovy offers superior flexibility with 6 weeks room temperature stability below 30°C once removed from the fridge. Mounjaro provides only 21 days room temperature storage, making Wegovy more suitable for extended travel or situations where refrigeration access is limited. The FlexTouch pen design used by Wegovy features an intuitive dose counter and comfortable grip, though both medications use similar pre-filled pen formats. Weekly injection schedules for both medications provide convenience compared to daily treatments, with flexible timing allowing you to choose the most suitable day and time for your routine.
Complete Dose Journey: Why Having Every Strength Matters For Wegovy Success
The difference between successful and unsuccessful weight management often lies in having access to every dose throughout your journey. Many patients require extended periods at intermediate doses (0.5mg or 1mg) before progressing, while others may need to step back temporarily due to side effects before resuming escalation. Our comprehensive stock ensures these individual variations never disrupt your treatment continuity. Some patients find their optimal maintenance dose at 1.7mg rather than the full 2.4mg, requiring long-term access to this intermediate strength.
Unlike pharmacies with limited stock ranges, EverydayMeds maintains every Wegovy dose from initial 0.25mg through maximum 2.4mg maintenance. This complete availability becomes crucial during supply chain disruptions affecting individual strengths, ensuring your treatment continues uninterrupted. Our bundle options support various progression patterns, whether you prefer gradual escalation with our Take-It-Slow range or standard progression with Getting Started bundles. This comprehensive approach recognises that weight management is a long-term commitment requiring flexible, reliable pharmaceutical support.
Making The Right Choice: Both Wegovy And Mounjaro Available From EverydayMeds
Rather than viewing the difference between Mounjaro and Wegovy as a competition, consider them complementary options addressing different patient needs and preferences. Some individuals respond better to GLP-1 single-receptor targeting, while others may benefit from Mounjaro's dual mechanism approach. Factors influencing choice include previous treatment response, side effect tolerance, injection frequency preferences, and specific health conditions requiring consideration. Your prescriber evaluates these factors alongside clinical guidelines to recommend the most appropriate option, with the flexibility to switch if initial choice proves suboptimal.
EverydayMeds supports both pathways with complete dose ranges, competitive pricing, and expert clinical guidance throughout your journey. Our online platform allows easy comparison of mechanisms, costs, and practical considerations, while our clinical team remains available for questions about either medication. Whether you begin with Wegovy's proven GLP-1 approach or explore Mounjaro's innovative dual mechanism, our comprehensive service ensures optimal support from assessment through long-term maintenance. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment, with codes FIRST40 or DOSE25 applied at checkout for optimal pricing.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
